A New Approach to a Personalized Patient Blood Management Program (pPBM) in Total Hip Arthroplasty (THA)

A New Approach to a Personalized Patient Blood Management Program in Total Hip Arthroplasty

The study evaluates the patient related risk and predictive factors concerning perioperative homologous blood cell transfusion (erythrocyte concentrate ) in THA patients in one EndoCert max-certified orthopedic hospital in Germany.

A patient oriented preoperative decision-making algorithm (a personalised Patient Blood Management or pPBM App) will be developed as a new patient-safety blood-sparing strategy.

The aim is to increase the patient safety by using the pPBM App and to reach a more efficient management of resources.

Retrospective audit of 470 consecutive primary THA in 2013 and 2014

Inclusion Criteria:

• primary THA on patients with coxarthrosis

Exclusion Criteria:

• any kind of old or acute fractures about the basin and hip
• combined surgery, like first extracting a femur nail and than undergoing THA
• any other kind of combined or simultaneous surgery
• any kind of coagulopathy